Iodură De Potasiu G.L. Pharma (Potassium Iodide)

Potassium iodide provides stable iodide ions that are quickly absorbed and taken up by the thyroid gland. By saturating the gland’s iodine pool, it blocks the uptake of radioactive iodine isotopes and reduces the substrate available for thyroid hormone synthesis, thereby limiting thyroid stimulation during exposure or deficiency.

The appropriate dose of potassium iodide is determined by a qualified prescriber based on the specific indication, patient age, weight, and clinical context. Healthcare professionals follow national or institutional guidelines to select the correct amount for thyroid protection or iodine supplementation.

Safety data for potassium iodide in pregnancy and lactation are limited. Pregnant or breastfeeding individuals should discuss potential risks and benefits with their healthcare provider, who can decide whether the medication is appropriate based on the clinical situation and available alternatives.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. The sales team then provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Potassium iodide is the standard oral iodide used for rapid thyroid blockade in radiation emergencies. Compared with other agents such as perchlorate or thiocyanate, potassium iodide provides a more immediate and reliable saturation of the thyroid gland, with a well‑established safety profile when used as directed.

Iodură De Potasiu G.L. Pharma should be stored at ambient temperature below 25 °C. Keep the product in its original packaging, protect it from moisture, and store it away from direct sunlight or heat sources to maintain stability and potency.

Potassium iodide is administered orally, typically as a tablet, capsule, or liquid solution. The exact form and dosing schedule are prescribed by a healthcare professional, who will also advise on timing relative to any potential radioactive iodine exposure.

Serious risks include severe allergic reactions such as anaphylaxis, significant thyroid dysfunction (both hypo‑ and hyperthyroidism), and rare but severe skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms such as swelling of the face or tongue, difficulty breathing, or a widespread rash.

Potassium iodide should be avoided in individuals with known hypersensitivity to iodide compounds, those with uncontrolled thyroid disorders without medical supervision, and patients with certain kidney conditions where potassium balance may be compromised. A healthcare provider should evaluate suitability before initiating therapy.